Table 4.
Effect of CLHE and CFHE on liver LPO, GSH content, and SOD and GPx activities among the study groups.
| Group (n = 6) | LPO (nmole/100 mg tissue (hr)) | GSH (nmole ∕100 mg tissue) | SOD (U∕gm tissue) | GPx (mU∕100 mg tissue) |
|---|---|---|---|---|
| Negative control | 24.85 ± 2.94b | 58.38 ± 5.93a | 18.66 ± 0.51a | 117.66 ± 13.35a |
| Diabetic control | 59.80 ± 1.79a | 22.71 ± 0.34b | 16.50 ± 0.54c | 66.66 ± 16.64c |
| Diabetic group treated with CLHE | 28.25 ± 1.59c | 23.76 ± 3.85b | 17.33 ± 0.52b | 92.33 ± 3.65b |
| Diabetic group treated with CFHE | 42.00 ± 4.17d | 22.96 ± 0.37b | 17.50 ± 0.83b | 97.33 ± 31.08ab |
Data were expressed as mean ± SD. For each variable, values that do not share the same superscript letter (a, b, and c) were significantly different at p < 0.05. LPO, lipid peroxidation; GSH, glutathione; SOD, superoxide dismutase; GPx, glutathione peroxidase; CLHF, C. scolymus leaf hydroethanolic extract; CFHE, C. scolymus flower hydroethanolic extract.